Jonathan Mark Bridges, MD - Medicare Hematology/oncology in Birmingham, AL

Jonathan Mark Bridges, MD is a medicare enrolled "Internal Medicine - Hematology & Oncology" physician in Birmingham, Alabama. He went to University Of South Carolina School Of Medicine and graduated in 2002 and has 22 years of diverse experience with area of expertise as Hematology/oncology. He is a member of the group practice The Sylacauga Health Care Authority, Hematology And Oncology Associates Of Alabama Llc and his current practice location is 513 Brookwood Blvd, Suite 275, Birmingham, Alabama. You can reach out to his office (for appointments etc.) via phone at (205) 502-4700.

Jonathan Mark Bridges is licensed to practice in Alabama (license number 26776) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1598979973.

Contact Information

Jonathan Mark Bridges, MD
513 Brookwood Blvd, Suite 275,
Birmingham, AL 35209-6862
(205) 502-4700
(205) 502-5183



Physician's Profile

Full NameJonathan Mark Bridges
GenderMale
SpecialityHematology/oncology
Experience22 Years
Location513 Brookwood Blvd, Birmingham, Alabama
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Jonathan Mark Bridges attended and graduated from University Of South Carolina School Of Medicine in 2002
  NPI Data:
  • NPI Number: 1598979973
  • Provider Enumeration Date: 05/09/2007
  • Last Update Date: 02/10/2015
  Medicare PECOS Information:
  • PECOS PAC ID: 3678645553
  • Enrollment ID: I20080709000590

Medical Identifiers

Medical identifiers for Jonathan Mark Bridges such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1598979973NPI-NPPES
510-12252OtherALBLUECROSS BLUESHIELD (SYLACAUGA)
1598979973MedicaidAL
510-12242OtherALBLUECROSS BLUESHIELD (BIRMINGHAM)

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207RH0003XInternal Medicine - Hematology & Oncology 26776 (Alabama)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Coosa Valley Medical CenterSylacauga, ALHospital
Brookwood Baptist Medical CenterBirmingham, ALHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
The Sylacauga Health Care Authority529471039828
Hematology And Oncology Associates Of Alabama Llc98300985168

News Archive

Evolutionary snapshot reveals genetic stability of SARS-CoV-2

A multinational study currently available on the bioRxiv preprint server shows that in the early large genome of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) only a handful of amino acids are exchanged, implying a relatively low mutation rate and selection pressure.

Researcher to examine if music intervention can alleviate distress in young cancer patients and parents

An Indiana University School of Nursing researcher has been awarded $1.4 million to determine if a music therapy intervention can be used to manage acute distress in young cancer patients ages 3 to 8 and their parents.

Pneumonia-causing diseases kill 1.2m children under 5 annually, Studies say

"Each year 1.2 million children under age 5 die from Streptococcus pneumoniae and Haemophilus influenzae B or Hib," which cause pneumococcal disease and are preventable with vaccines, according to studies published Thursday in the journal Lancet, Reuters reports.

Brain-transportable soy derivate reduces memory degradation in mice

In a study that could help one day give a literal meaning to food for thought, researchers from Kyushu University in Japan have reported that a protein fragment that makes its way into the brain after being ingested can reduce memory degradation in mice treated to simulate Alzheimer's disease.

Tomorrow Options develops microelectronic device to treat bedsores

Small, light and simple. These are the three key characteristics of MovinSense, a microelectronic device developed by Tomorrow Options, a spin-off from INESC TEC/FEUP. The device is placed on the chest of the bedridden patient with limited mobility and it registers their position, communicating with nursing equipment via wireless.

Read more Medical News

› Verified 2 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Jonathan Mark Bridges allows following entities to bill medicare on his behalf.
Entity NameHematology & Oncology Associates Of Alabama Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1134232770
PECOS PAC ID: 9830098516
Enrollment ID: O20031231000568

News Archive

Evolutionary snapshot reveals genetic stability of SARS-CoV-2

A multinational study currently available on the bioRxiv preprint server shows that in the early large genome of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) only a handful of amino acids are exchanged, implying a relatively low mutation rate and selection pressure.

Researcher to examine if music intervention can alleviate distress in young cancer patients and parents

An Indiana University School of Nursing researcher has been awarded $1.4 million to determine if a music therapy intervention can be used to manage acute distress in young cancer patients ages 3 to 8 and their parents.

Pneumonia-causing diseases kill 1.2m children under 5 annually, Studies say

"Each year 1.2 million children under age 5 die from Streptococcus pneumoniae and Haemophilus influenzae B or Hib," which cause pneumococcal disease and are preventable with vaccines, according to studies published Thursday in the journal Lancet, Reuters reports.

Brain-transportable soy derivate reduces memory degradation in mice

In a study that could help one day give a literal meaning to food for thought, researchers from Kyushu University in Japan have reported that a protein fragment that makes its way into the brain after being ingested can reduce memory degradation in mice treated to simulate Alzheimer's disease.

Tomorrow Options develops microelectronic device to treat bedsores

Small, light and simple. These are the three key characteristics of MovinSense, a microelectronic device developed by Tomorrow Options, a spin-off from INESC TEC/FEUP. The device is placed on the chest of the bedridden patient with limited mobility and it registers their position, communicating with nursing equipment via wireless.

Read more Medical News

› Verified 2 days ago

Entity NameThe Sylacauga Health Care Authority
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1124235320
PECOS PAC ID: 5294710398
Enrollment ID: O20040727001079

News Archive

Evolutionary snapshot reveals genetic stability of SARS-CoV-2

A multinational study currently available on the bioRxiv preprint server shows that in the early large genome of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) only a handful of amino acids are exchanged, implying a relatively low mutation rate and selection pressure.

Researcher to examine if music intervention can alleviate distress in young cancer patients and parents

An Indiana University School of Nursing researcher has been awarded $1.4 million to determine if a music therapy intervention can be used to manage acute distress in young cancer patients ages 3 to 8 and their parents.

Pneumonia-causing diseases kill 1.2m children under 5 annually, Studies say

"Each year 1.2 million children under age 5 die from Streptococcus pneumoniae and Haemophilus influenzae B or Hib," which cause pneumococcal disease and are preventable with vaccines, according to studies published Thursday in the journal Lancet, Reuters reports.

Brain-transportable soy derivate reduces memory degradation in mice

In a study that could help one day give a literal meaning to food for thought, researchers from Kyushu University in Japan have reported that a protein fragment that makes its way into the brain after being ingested can reduce memory degradation in mice treated to simulate Alzheimer's disease.

Tomorrow Options develops microelectronic device to treat bedsores

Small, light and simple. These are the three key characteristics of MovinSense, a microelectronic device developed by Tomorrow Options, a spin-off from INESC TEC/FEUP. The device is placed on the chest of the bedridden patient with limited mobility and it registers their position, communicating with nursing equipment via wireless.

Read more Medical News

› Verified 2 days ago

Entity NameHematology & Oncology Associates Of Alabama Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1528251642
PECOS PAC ID: 9830098516
Enrollment ID: O20080116000129

News Archive

Evolutionary snapshot reveals genetic stability of SARS-CoV-2

A multinational study currently available on the bioRxiv preprint server shows that in the early large genome of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) only a handful of amino acids are exchanged, implying a relatively low mutation rate and selection pressure.

Researcher to examine if music intervention can alleviate distress in young cancer patients and parents

An Indiana University School of Nursing researcher has been awarded $1.4 million to determine if a music therapy intervention can be used to manage acute distress in young cancer patients ages 3 to 8 and their parents.

Pneumonia-causing diseases kill 1.2m children under 5 annually, Studies say

"Each year 1.2 million children under age 5 die from Streptococcus pneumoniae and Haemophilus influenzae B or Hib," which cause pneumococcal disease and are preventable with vaccines, according to studies published Thursday in the journal Lancet, Reuters reports.

Brain-transportable soy derivate reduces memory degradation in mice

In a study that could help one day give a literal meaning to food for thought, researchers from Kyushu University in Japan have reported that a protein fragment that makes its way into the brain after being ingested can reduce memory degradation in mice treated to simulate Alzheimer's disease.

Tomorrow Options develops microelectronic device to treat bedsores

Small, light and simple. These are the three key characteristics of MovinSense, a microelectronic device developed by Tomorrow Options, a spin-off from INESC TEC/FEUP. The device is placed on the chest of the bedridden patient with limited mobility and it registers their position, communicating with nursing equipment via wireless.

Read more Medical News

› Verified 2 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Jonathan Mark Bridges is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Jonathan Mark Bridges, MD
Po Box 131329,
Birmingham, AL 35213-6329

Ph: (205) 271-8541
Jonathan Mark Bridges, MD
513 Brookwood Blvd, Suite 275,
Birmingham, AL 35209-6862

Ph: (205) 502-4700

News Archive

Evolutionary snapshot reveals genetic stability of SARS-CoV-2

A multinational study currently available on the bioRxiv preprint server shows that in the early large genome of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) only a handful of amino acids are exchanged, implying a relatively low mutation rate and selection pressure.

Researcher to examine if music intervention can alleviate distress in young cancer patients and parents

An Indiana University School of Nursing researcher has been awarded $1.4 million to determine if a music therapy intervention can be used to manage acute distress in young cancer patients ages 3 to 8 and their parents.

Pneumonia-causing diseases kill 1.2m children under 5 annually, Studies say

"Each year 1.2 million children under age 5 die from Streptococcus pneumoniae and Haemophilus influenzae B or Hib," which cause pneumococcal disease and are preventable with vaccines, according to studies published Thursday in the journal Lancet, Reuters reports.

Brain-transportable soy derivate reduces memory degradation in mice

In a study that could help one day give a literal meaning to food for thought, researchers from Kyushu University in Japan have reported that a protein fragment that makes its way into the brain after being ingested can reduce memory degradation in mice treated to simulate Alzheimer's disease.

Tomorrow Options develops microelectronic device to treat bedsores

Small, light and simple. These are the three key characteristics of MovinSense, a microelectronic device developed by Tomorrow Options, a spin-off from INESC TEC/FEUP. The device is placed on the chest of the bedridden patient with limited mobility and it registers their position, communicating with nursing equipment via wireless.

Read more News

› Verified 2 days ago


Internal Medicine Doctors in Birmingham, AL

Juan Mario Bernal, M.D.
Hematology & Oncology
Medicare: Accepting Medicare Assignments
Practice Location: 3680 Grandview Pkwy Ste 200, Birmingham, AL 35243
Phone: 205-971-7500    
Dr. William Randolph Maddox, M.D.
Hematology & Oncology
Medicare: Accepting Medicare Assignments
Practice Location: 701 Princeton Ave Sw, Birmingham, AL 35211
Phone: 205-783-3000    Fax: 205-297-9411
Jodie Ann Dionne, MD
Hematology & Oncology
Medicare: Accepting Medicare Assignments
Practice Location: 703 19th St S Bldg 206, Birmingham, AL 35233
Phone: 205-975-6530    
Dr. Karl Tullio Schroeder, M.D.
Hematology & Oncology
Medicare: Accepting Medicare Assignments
Practice Location: 817 Princeton Ave Sw Ste 199, Birmingham, AL 35211
Phone: 205-780-1920    Fax: 205-780-2345
Dr. Deepti Bahl, MD
Hematology & Oncology
Medicare: Accepting Medicare Assignments
Practice Location: 2000 6th Ave S, Birmingham, AL 35233
Phone: 205-934-9999    
Amitkumar Mehta,
Hematology & Oncology
Medicare: Accepting Medicare Assignments
Practice Location: 1720 2nd Ave S # Np2540t, Birmingham, AL 35294
Phone: 205-996-8400    Fax: 205-934-1608
Shana Monika Machado, D.O.
Hematology & Oncology
Medicare: Medicare Enrolled
Practice Location: 619 19th St S, Birmingham, AL 35249
Phone: 205-934-4011    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.